Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells

Hypertension

Volumn 32, Issue 6, 1998, Pages 1083-1088

  Marumo, Takeshi ^a   Schini Kerth, Valérie B ^a   Brandes, Ralf P ^a   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Free radicals; Glucocorticoids; Muscle, smooth, vascular; NADH; NADPH oxidase; Superoxide

Indexed keywords

DEXAMETHASONE; FLUORESCEIN DERIVATIVE; GLUCOCORTICOID; HYDROCORTISONE; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PREDNISOLONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; ENZYME ACTIVITY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HYPERTENSION; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0032406714     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.6.1083     Document Type: Article

References (41)

1. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 1995;26:854-857.
2. Suzuki H, Swei A, Zweifach BW, Schmid-Schönbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats: hydroethidine microfluorography. Hypertension. 1995;25: 1083-1089.
3. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
4. Swei A, Lacy F, Delano FA, Schmid-Schönbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension. 1997;30:1628-1633.
5. Bouloumié A, Bauersachs J, Linz W, Schölkens BA, Wiemer G, Fleming I, Busse R. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension. 1997;30:934-941.
6. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91: 2546-2551.
7. White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci U S A. 1996;93:8745-8749.
8. 2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299.
9. 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol 1997;121:665-670.
10. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation. 1997;96:2361-2367.
11. Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest. 1986;77:757-761.
12. Mietussnyder M, Friera A, Glass CK, Pitas RE. Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress. Arterioscler Thromb Vasc Biol. 1997;17:969-978.
13. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271: 23317-23321.
14. Fukui T, Ishizaka N, Rajagopalan S, Lauren JB, Capers Q, Taylor WR, Harrison DG, Deleon H, Wilcox JN, Griendling KK. p22 phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45-51.
15. Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med. 1986;80:925-929.
16. Asai K, Funaki C, Hayashi T, Yamada K, Naito M, Kuzuya M, Yoshida F, Yoshimine N, Kuzuya F. Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits: possible mechanisms. Arterioscler Thromb. 1993;13:892-899.
17. Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest. 1994;93:1243-1249.
18. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells: effects on cell proliferation. Circ Res. 1992;71: 1088-1100.
19. 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol. 1994;126: 1079-1088.
20. Zulueta JJ, Sawhney R, Yu FS, Cote CC, Hassoun PM. Intracellular generation of reactive oxygen species in endothelial cells exposed to anoxia-reoxygenation. Am J Physiol. 1997;272:L897-L902.
21. Crapo JD, McCord JM, Fridovich I. Preparation and assay of superoxide dismutases. Methods Enzymol. 1978;53:382-393.
22. Fukui T, Lassegue B, Kai H, Alexander RW, Griendling KK. Cytochrome b-558 α-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta. 1995;1231:215-219.
23. Marumo T, Nakaki T, Nagata K, Miyata M, Adachi H, Esumi H, Suzuki H, Saruta T, Kato R. Dexamethasone inhibits nitric oxide synthase mRNA induction by interleukin-1α and tumor necrosis factor-α in vascular smooth muscle cells. Jpn J Pharmacol. 1993;63: 361-367.
24. Speir E, Shibutani T, Yu ZX, Ferrans V, Epstein SE. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res. 1996;79:1143-1152.
25. Cathcart R, Schwiers E, Ames BN. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem. 1983;134:111-116.
26. Thelen M, Dewald B, Baggiolini M. Neutrophil signal transduction and activation of the respiratory burst. Physiol Rev. 1993;73:797-821.
27. O'Donnell VB, Smith GCM, Jones OTG. Involvement of phenyl radicals in iodonium compound inhibition of flavoenzymes. Mol Pharmacol. 1994;46:778-785.
28. Amezaga MA, Bazzoni F, Sorio C, Rossi F, Cassatella MA. Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon γ-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (FcγR-I) in human polymorphonuclear leukocytes. Blood. 1992;79:735-744.
29. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akitas H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation. 1998;97:135-137.
30. 2 for activation of the phagocyte NADPH oxidase. J Biol Chem. 1998;273:441-445.
31. 2(s): comparison of arachidonoyl-selective and -nonselective enzymes FASEB J. 1993;7:339-348.
32. Shibutani T, Johnson TM, Yu ZX, Ferrans VJ, Moss J, Epstein SE. Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J Clin Invest. 1997;100:2054-2061.
33. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, Leslie CC, Krebs EG. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem. 1996;271:505-511.
34. Sato A, Suzuki H, Murakami M, Nakazato Y, Iwaita Y, Saruta T. Glucocorticoid increases angiotensin II type 1 receptor and its gene expression. Hypertension. 1994;23:25-30.
35. Schelling JR, DeLuca DJ, Konieczkowski M, Marzec R, Sedor JR, Dubyak GR, Linas SL. Glucocorticoid uncoupling of angiotensin II-dependent phospholipase C activation in rat vascular smooth muscle cells. Kidney Int. 1994;46:675-682.
36. Petrichenko IE, Daret D, Kolpakova GV, Shakhov YA, Larrue J. Glucocorticoids stimulate cholesleryl ester formation in human smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:1143-1151.
37. Fishel RS, Eisenberg S, Shai-Yung S, Redden RA, Bernstein KE, Berk BC. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension, 1995;25:343-349.
38. Laurindo FR, Pedro MdA, Barbeiro HV, Pileggi F, Carvalho MH, Augusto O, da Luz PL. Vascular free radical release: ex vivo and in vivo evidence for a flow-dependent endothelial mechanism. Circ Res. 1994;74:700-709.
39. Hishikawa K, Lüscher TF. Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. Circulation. 1997;96: 3610-3616.
40. 2+/EDRF signaling are due to generation of superoxide anions. Diabetes. 1996;45:1386-1395.
41. Pritchard KA Jr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS, Stemerman MB. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res. 1995;77:510-518.